Elan Prialt Intrathecal Delivery Effectively Limits Use To Experts, FDA Concludes

Intrathecal administration effectively limits use of Elan's Prialt (ziconotide) to specialists, a de facto restriction that tempered FDA concerns about a drug characterized by what one agency official called "profound toxicity" and "meager" efficacy